Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee Osteoarthritis

Sponsor
PharmaResearch Co.,Ltd
Study ID
NCT07646483
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Conjuran — DEVICE
    Once a week for 5 injections
  • Hyruan — DRUG
    Once a week for 5 injections

Study Details

This clinical trial aims to evaluate and compare the efficacy and safety of Conjuran® and Hyruan in patients with knee osteoarthritis following first and second cycle (repeat) administration.

Key Dates

First listed
Jun 12, 2026
Start date
Jun 30, 2026
Status verified
Jun 2026
Primary completion
Sep 30, 2027
Completion
Jul 31, 2028

Study Design

Enrollment
180 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Conjuran
    Once a week for 5 injections
  • Active Comparator: Hyruan
    Once a week for 5 injections

Primary Outcome Measure

Weight-Bearing Pain (WBP) Visual Analog Scale (VAS) [ Time Frame: Week 16 ]

Find similar trials

Nationwide
Osteoarthritis (other) trialsOrthopedics trialsMusculoskeletal disorders trials

Related Studies